Our findings also suggest that NOTCH1 and NOTCH2-driven breast cancers may represent a distinct biological form of breast cancer that is driven in part through the silencing of the PTEN tumor suppressor gene, in addition to the activation of oncogene targets such as MYC56. The gene discussed is NOTCH2; the disease is breast cancer.